Best Compounds for Longevity: Evidence-Based Rankings
The quest for extended healthspan—years lived in good health—has driven scientific investigation into compounds that may slow aging and promote longevity. While no substance guarantees extended life, evidence-based research identifies compounds with varying levels of support for longevity-related outcomes including muscle preservation, cognitive function, cardiovascular health, and immune resilience.
This guide ranks the most promising longevity compounds based on the strength of human evidence, effect sizes, and mechanistic plausibility. Understanding these rankings helps distinguish between supplements with robust clinical support and those requiring further investigation.
Why Evidence-Based Supplementation Matters
Aging involves interconnected biological processes: muscle loss (sarcopenia), cognitive decline, immune senescence, cardiovascular deterioration, and systemic inflammation. Many compounds address one or more of these hallmarks, but the quality of evidence varies dramatically. Compounds ranked in this guide undergo rigorous assessment based on:
- Study design quality: Randomized controlled trials (RCTs) rank higher than observational studies
- Sample size: Larger trials provide more reliable estimates
- Replication: Independent research teams confirming findings
- Effect sizes: Magnitude of measured improvements
- Direct longevity endpoints: Mortality, lifespan, or healthspan data
Tier 4: Strong Evidence for Aging-Related Outcomes (Limited Direct Longevity Data)
Creatine Monohydrate
What it is: A naturally occurring compound stored in muscle cells that regenerates adenosine triphosphate (ATP), the cell's primary energy currency. Creatine monohydrate is the most researched form and is naturally found in meat and fish.
Evidence tier: Tier 4 — Strong evidence for functional improvements in aging populations, limited direct longevity data
Key findings:
- Combined with resistance training, creatine increased lean tissue mass across 12 randomized controlled trials (n=357 older adults, p<0.0001)
- Chest press strength improved significantly (p=0.004) as did leg press strength (p=0.02) versus resistance training alone
- Emerging evidence suggests cognitive benefits in aging populations
Dosing: 3-5g daily, taken consistently. No loading phase required, though some protocols use 20g daily divided into 4 doses for 5-7 days.
Cost: $10-20 monthly
Collagen Peptides
What it is: Short-chain amino acid sequences derived from animal collagen, particularly targeting skin and connective tissue health. Bioactive peptides contain specific amino acids including glycine, proline, and hydroxyproline.
Evidence tier: Tier 4 — Strong evidence for skin health markers; emerging evidence for musculoskeletal benefits
Key findings:
- Skin wrinkle reduction of 20% after 8 weeks of 2.5g daily bioactive collagen peptides, maintained 4 weeks after supplementation ended
- Procollagen I increased 65% and elastin increased 18% in 114 women (PMID: 24401291)
- Consistent replication across multiple well-designed human RCTs with clinically meaningful effect sizes
Dosing: 2.5-10g daily, taken with vitamin C for optimal synthesis
Cost: $15-30 monthly
Ginkgo Biloba
What it is: A plant extract from the Ginkgo biloba tree, traditionally used in Asian medicine. The standardized extract EGb 761 contains specific ratios of ginkgo flavone glycosides and terpene lactones.
Evidence tier: Tier 4 — Strong evidence for cognitive improvements; addresses cognitive symptoms rather than lifespan extension
Key findings:
- Meta-analysis of 9 RCTs (n=2,561 patients, 22-26 weeks): EGb 761 at 240 mg/day improved cognition versus placebo with weighted mean difference of -2.86 (95% CI -3.18 to -2.54)
- Improved activities of daily living (SMD -0.36, 95% CI -0.44 to -0.28)
- Improved global clinician impression (OR 1.88, 95% CI 1.54-2.29) (PMID 25114079)
Dosing: 120-240mg daily, typically divided into 3 doses
Cost: $10-15 monthly
Tier 3: Probable Efficacy for Longevity-Related Outcomes
Ashwagandha
What it is: An adaptogenic herb (Withania somnifera) from Ayurvedic medicine containing withanolides, bioactive compounds that modulate stress hormones and inflammatory pathways.
Evidence tier: Tier 3 — Probable efficacy with multiple RCTs; limited by small sample sizes and short durations
Key findings:
- VO2 max increased 5.67 ml/kg/min with ashwagandha versus 1.86 ml/kg/min with placebo at 12 weeks in healthy athletes (n=50, RCT, p<0.0001)
- Multiple RCTs demonstrate improvements in physical performance, muscle strength, cognitive function, and inflammatory markers
- Most studies last 8-12 weeks; long-term follow-up data remains limited
Dosing: 300-600mg daily of standardized extract (2-3% withanolides)
Cost: $15-25 monthly
Thymosin Alpha-1
What it is: A naturally occurring 28-amino acid peptide produced by the thymus gland that regulates immune cell development and function. Synthetic versions are used clinically.
Evidence tier: Tier 3 — Probable efficacy for immune function in aging; limited by small sample sizes and lack of independent replication
Key findings:
- Influenza antibody response rate significantly higher in elderly men (age 65-99) receiving thymosin alpha-1 versus placebo with standard flu vaccine (n=85, double-blind RCT)
- Demonstrates improved vaccine responses and immune cell counts
- Lacks large-scale independent replication and direct longevity outcome measures
Dosing: Typically 1.6mg subcutaneously, 2-3 times weekly
Cost: $200-400 monthly (pharmaceutical grade)
Tesamorelin
What it is: A synthetic peptide that stimulates growth hormone-releasing hormone (GHRH) receptors, increasing endogenous growth hormone secretion. FDA-approved for lipodystrophy in HIV patients.
Evidence tier: Tier 3 — Probable benefits for body composition; emerging cognitive function evidence; core longevity markers unproven
Key findings:
- Reduced waist circumference significantly more than standard of care in HIV+ adults with abdominal obesity (6-month RCT, n=73, P<0.05)
- Demonstrates consistent effects on body composition
- Emerging evidence for cognitive function in aging populations remains inconclusive
Dosing: 2mg subcutaneously daily
Cost: $250-500 monthly
GHRP-2
What it is: A synthetic hexapeptide that stimulates growth hormone secretion through ghrelin receptor activation. Robustly increases pulsatile and non-pulsatile growth hormone release.
Evidence tier: Tier 3 — Robust GH secretion documented; no direct longevity outcome data
Key findings:
- GHRP-2 infusion stimulated GH secretion 4.4-fold in basal mode and burst mass amplified 1.9- to 8.8-fold when combined with estradiol in postmenopausal women (n=10, RCT)
- Consistent, reproducible GH-releasing efficacy across multiple controlled human studies
- No trials have measured lifespan, healthspan, or age-related mortality endpoints
Dosing: 100-200 micrograms 2-3 times daily subcutaneously
Cost: $300-600 monthly
Follistatin 344
What it is: A protein that inhibits myostatin, a negative regulator of muscle growth. Recombinant versions enhance muscle development and reduce age-related muscle loss.
Evidence tier: Tier 3 — Probable efficacy for sarcopenia markers; limited by small samples and short durations
Key findings:
- In healthy older women (n=96, RCT), resistance exercise combined with essential amino acid supplementation increased muscle mass significantly and elevated the follistatin/myostatin ratio
- Supports improvements in muscle quality and sarcopenia markers
- 4 RCTs demonstrate consistent increases in the follistatin/myostatin ratio
- Evidence limited by 8-12 week intervention durations and small sample sizes
Dosing: Typically 100-200 micrograms via subcutaneous injection
Cost: $400-800 monthly
Thymalin
What it is: A peptide extracted from the thymus gland that supports immune function and has been studied as an anti-aging intervention in European and Russian populations.
Evidence tier: Tier 3 — Probable efficacy based on single moderate-quality RCT; lacks independent replication
Key findings:
- Thymalin monotherapy reduced mortality 2.0-2.1-fold in 266 elderly subjects over 6-8 years with initial 2-3 years of treatment (human RCT, PMID 14523363)
- Consistent animal studies and mechanistic evidence support immune-supporting mechanisms
- Limited by single human RCT without independent replication and incomplete methodological reporting
Dosing: 10-20mg intramuscularly or subcutaneously
Cost: $150-300 monthly
Cerebrolysin
What it is: A standardized, purified peptide and amino acid mixture derived from porcine brain tissue. Contains low-molecular-weight peptides and free amino acids that cross the blood-brain barrier.
Evidence tier: Tier 3 — Probable efficacy for cognitive decline; limited by small sample sizes and lack of large-scale RCT replication
Key findings:
- Meta-analysis of 6 human RCTs: cerebrolysin improved cognitive function (SMD -0.40, p=0.0031 at 4 weeks) and global clinical change in mild-to-moderate Alzheimer's disease
- 76% responder rate versus 57% placebo (p=0.007)
- Consistent animal data supports neuroprotective mechanisms
- Limited by short treatment durations and small sample sizes
Dosing: 10-30mL intravenous infusion daily for 10-20 days, then periodic maintenance
Cost: $200-400 per treatment course
Ibutamoren (MK-677)
What it is: A non-peptide growth hormone secretagogue that stimulates GH and IGF-I secretion by mimicking ghrelin action at the hypothalamus and anterior pituitary.
Evidence tier: Tier 3 — Probable efficacy for GH/IGF-I restoration in elderly; no direct lifespan or mortality data
Key findings:
- 25 mg/day MK-677 increased mean 24-hour GH concentration 97±23% in elderly subjects over 14 days (n=32, human RCT, PMID 8954023)
- Restores growth hormone and IGF-I axis function in elderly subjects
- Limited to 3 small human RCTs with short durations; no lifespan data available
Dosing: 10-25mg daily
Cost: $100-200 monthly
GLP-1 Receptor Agonists
What it is: Glucagon-like peptide-1 mimetics that enhance insulin secretion, slow gastric emptying, and activate receptors throughout the nervous and cardiovascular systems. Originally developed for diabetes management.
Evidence tier: Tier 3 — Plausible mechanisms; mixed human evidence; mechanistic studies support anti-aging potential with some concerns
Key findings:
- Epidemiological analysis in long-term GLP-1RA users shows reduced incidence of dementia, Parkinson disease, and multiple sclerosis
- Mechanistic studies suggest reduced neurodegeneration, improved cardiovascular and metabolic health, and reduced ocular aging
- Concerns about muscle mass loss and facial aging complicate longevity benefit profile
- Human proof of longevity extension remains absent
Dosing: Varies by agent; typically 0.25-2.4mg weekly (semaglutide)
Cost: $200-1,000 monthly depending on formulation
Argireline
What it is: A synthetic hexapeptide (acetyl hexapeptide-3) that modulates acetylcholine release at the neuromuscular junction, reducing facial muscle contractions and minimizing wrinkle formation.
Evidence tier: Tier 3 — Probable efficacy for skin aging; limited replication and short study durations
Key findings:
- 48.9% reduction in peri-orbital wrinkles with Argireline versus 0% in placebo group over 4 weeks in human RCT (n=60, Wang et al. 2013)
- ~48% anti-wrinkle effects and improvements in skin texture across 2 RCTs
- Limited by small sample sizes, 4-6 week treatment durations, and lack of independent replication
Dosing: Topical application, typically 3-10% concentration, twice daily
Cost: $30-80 monthly
Omega-3 Fatty Acids
What it is: Essential polyunsaturated fatty acids (EPA and DHA) found in fish oil and algae sources. Support cardiovascular health, neurological function, and inflammatory regulation.
Evidence tier: Tier 3 — Probable benefits for multiple longevity outcomes; inconsistent results limit conclusive evidence
Key findings:
- Fish oil increased thigh muscle volume by 3.6% (95% CI: 0.2-7.0%, p<0.05) and handgrip strength by 2.3 kg (95% CI: 0.8-3.7 kg, p<0.05) in healthy older adults over 6 months (n=44, human RCT)
- Benefits documented for muscle mass, cardiovascular health, and cognitive function
- Efficacy not conclusively proven due to inconsistent results, modest effect sizes, and limited large-scale RCT data
Dosing: 1,000-3,000mg daily EPA+DHA combined
Cost: $10-25 monthly
Magnesium
What it is: An essential mineral cofactor for over 300 enzymatic reactions, critical for mitochondrial function, DNA synthesis, and cellular energy metabolism.
Evidence tier: Tier 3 — Probable benefits through multiple mechanisms; limited human evidence beyond observational data
Key findings:
- Higher dietary magnesium intake associated with longer leukocyte telomere length in US adults aged ≥45 years (β = 0.20 kp per 1 mg increase in log-transformed intake; n=4,039, observational)
- Highest tertile (≥299 mg/day) versus lowest (<198 mg/day) showed 0.07 kp longer telomeres (p=0.038)
- Benefits suggested for telomere preservation, mitochondrial function, and reduced inflammation
- Evidence remains limited to small observational studies and short-duration RCTs
Dosing: 200-400mg daily, taken with food to minimize gastrointestinal effects
Cost: $5-15 monthly